ArticleJournal of gastroenterology and hepatology2022

Long-term effectiveness of ustekinumab comparable to antitumor necrosis factor agents in patients with Crohn's disease.

Hisashi Shiga et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.